These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3806102)

  • 21. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK; Molloy BB
    Biochem Pharmacol; 1983 Apr; 32(7):1243-9. PubMed ID: 6847714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.
    O'Brien EM; Dostert P; Tipton KF
    Biochem Pharmacol; 1995 Jul; 50(3):317-24. PubMed ID: 7646533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
    J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding.
    Medvedev AE; Shvedov VI; Chulkova TM; Fedotova OA; Saederup E; Squires RF
    J Neural Transm Suppl; 1998; 52():337-42. PubMed ID: 9564636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tris (hydroxymethyl) aminomethane on amine oxidase activity in dog brain, liver and serum and in human placenta.
    Hayashi N; Kinemuchi H; Kamijo K
    Jpn J Pharmacol; 1981 Oct; 31(5):737-46. PubMed ID: 7311169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
    Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE
    Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA; Davies B; Castagnoli N
    Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl 1-alanine and its analogs.
    DeFeudis FV
    Rev Clin Basic Pharm; 1988; 7(1-4):207-8. PubMed ID: 3247497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):13-26. PubMed ID: 22032088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():13-26. PubMed ID: 25022028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amethocaine-induced inhibition of mitochondrial monoamine oxidase activity.
    Haque SJ; Poddar MK
    J Pharm Pharmacol; 1986 Nov; 38(11):858-60. PubMed ID: 2879023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase.
    O'Brien EM; Dostert P; Pevarello P; Tipton KF
    Biochem Pharmacol; 1994 Aug; 48(5):905-14. PubMed ID: 8093103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of debrisoquin on MAO A and MAO B activities.
    Javors MA; Bembenek ME; Bowden CL; Abell CW; Maas JW
    Life Sci; 1989; 45(24):2359-64. PubMed ID: 2601584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis.
    Medvedev AE; Ramsay RR; Ivanov AS; Veselovsky AV; Shvedov VI; Tikhonova OV; Barradas AP; Davidson CK; Moskvitina TA; Fedotova OA; Axenova LN
    Neurobiology (Bp); 1999; 7(2):151-8. PubMed ID: 10591049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photoaffinity labeling of human placental monoamine oxidase-A by 4-fluoro-3-nitrophenyl azide.
    Hsu MC; Shih JC
    Mol Pharmacol; 1988 Feb; 33(2):237-41. PubMed ID: 3340083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition.
    Pérez V; Marco JL; Fernández-Alvarez E; Unzeta M
    Br J Pharmacol; 1999 Jun; 127(4):869-76. PubMed ID: 10433493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.